APO Research
Talk to an analyst

APO RESEARCH · REPORT

API CDMO+CMC Service Platform

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global API CDMO+CMC Service Platform Market Analysis and Forecast 2026-2032

1 May 2026224 pages

Choose your research edition.

Industry ResearchAPI CDMO+CMC Service Platform Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal API CDMO+CMC Service Platform Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal API CDMO+CMC Service Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal API CDMO+CMC Service Platform Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal API CDMO+CMC Service Platform Market Analysis and Forecast 2026-2032224 pages · $4,950 USD

Market perspective

The global API CDMO+CMC Service Platform market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for API CDMO+CMC Service Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for API CDMO+CMC Service Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for API CDMO+CMC Service Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for API CDMO+CMC Service Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of API CDMO+CMC Service Platform include Lonza Group, Catalent, Inc., Thermo Fisher Scientific, Pfizer CentreOne, CordenPharma International, Boehringer Ingelheim BioXcellence, Recipharm AB, Changsha Jingyi Pharmaceutical Technology Co., Ltd. and GlaxoSmithKline, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for API CDMO+CMC Service Platform, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of API CDMO+CMC Service Platform, also provides the revenue of main regions and countries. Of the upcoming market potential for API CDMO+CMC Service Platform, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the API CDMO+CMC Service Platform revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global API CDMO+CMC Service Platform market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for API CDMO+CMC Service Platform revenue, projected growth trends, production technology, application and end-user industry.

API CDMO+CMC Service Platform Segment by Company

Lonza Group

Catalent, Inc.

Thermo Fisher Scientific

Pfizer CentreOne

CordenPharma International

Boehringer Ingelheim BioXcellence

Recipharm AB

Changsha Jingyi Pharmaceutical Technology Co., Ltd.

GlaxoSmithKline

Samsung BioLogics

Emergent BioSolutions

API CDMO+CMC Service Platform Segment by Type

Comprehensive CDMO Platform

Professional CDMO Platform

International CDMO Platform

API CDMO+CMC Service Platform Segment by Application

New Drug Development

Clinical Stage Production

Commercial Production

API CDMO+CMC Service Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global API CDMO+CMC Service Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of API CDMO+CMC Service Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of API CDMO+CMC Service Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of API CDMO+CMC Service Platform in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of API CDMO+CMC Service Platform company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, API CDMO+CMC Service Platform revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global API CDMO+CMC Service Platform Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Comprehensive CDMO Platform Major Player Table 3. Professional CDMO Platform Major Player Table 4. International CDMO Platform Major Player Table 5. Global API CDMO+CMC Service Platform Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. New Drug Development Major Player Table 7. Clinical Stage Production Major Player Table 8. Commercial Production Major Player Table 9. API CDMO+CMC Service Platform Industry Trends Table 10. API CDMO+CMC Service Platform Industry Drivers Table 11. API CDMO+CMC Service Platform Industry Opportunities and Challenges Table 12. API CDMO+CMC Service Platform Industry Restraints Table 13. Global API CDMO+CMC Service Platform Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global API CDMO+CMC Service Platform Market Size by Region (2021-2026) & (US$ Million) Table 15. Global API CDMO+CMC Service Platform Market Share by Region (2021-2026) Table 16. Global API CDMO+CMC Service Platform Market Size by Region (2027-2032) & (US$ Million) Table 17. Global API CDMO+CMC Service Platform Market Share by Region (2027-2032) Table 18. Global API CDMO+CMC Service Platform Revenue by Players (US$ Million) & (2021-2026) Table 19. Global API CDMO+CMC Service Platform Revenue Market Share by Players (2021-2026) Table 20. Global API CDMO+CMC Service Platform Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global API CDMO+CMC Service Platform Key Players Headquarters & Area Served Table 22. Global API CDMO+CMC Service Platform Players, Product Type & Application Table 23. Global API CDMO+CMC Service Platform Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global API CDMO+CMC Service Platform by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global API CDMO+CMC Service Platform Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global API CDMO+CMC Service Platform Revenue by Type (2021-2026) & (US$ Million) Table 28. Global API CDMO+CMC Service Platform Revenue by Type (2027-2032) & (US$ Million) Table 29. Global API CDMO+CMC Service Platform Revenue Market Share by Type (2021-2026) Table 30. Global API CDMO+CMC Service Platform Revenue Market Share by Type (2027-2032) Table 31. Global API CDMO+CMC Service Platform Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global API CDMO+CMC Service Platform Revenue by Application (2021-2026) & (US$ Million) Table 33. Global API CDMO+CMC Service Platform Revenue by Application (2027-2032) & (US$ Million) Table 34. Global API CDMO+CMC Service Platform Revenue Market Share by Application (2021-2026) Table 35. Global API CDMO+CMC Service Platform Revenue Market Share by Application (2027-2032) Table 36. Lonza Group Company Information Table 37. Lonza Group Business Overview Table 38. Lonza Group API CDMO+CMC Service Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Lonza Group API CDMO+CMC Service Platform Product Portfolio Table 40. Lonza Group Recent Development Table 41. Catalent, Inc. Company Information Table 42. Catalent, Inc. Business Overview Table 43. Catalent, Inc. API CDMO+CMC Service Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Catalent, Inc. API CDMO+CMC Service Platform Product Portfolio Table 45. Catalent, Inc. Recent Development Table 46. Thermo Fisher Scientific Company Information Table 47. Thermo Fisher Scientific Business Overview Table 48. Thermo Fisher Scientific API CDMO+CMC Service Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Thermo Fisher Scientific API CDMO+CMC Service Platform Product Portfolio Table 50. Thermo Fisher Scientific Recent Development Table 51. Pfizer CentreOne Company Information Table 52. Pfizer CentreOne Business Overview Table 53. Pfizer CentreOne API CDMO+CMC Service Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Pfizer CentreOne API CDMO+CMC Service Platform Product Portfolio Table 55. Pfizer CentreOne Recent Development Table 56. CordenPharma International Company Information Table 57. CordenPharma International Business Overview Table 58. CordenPharma International API CDMO+CMC Service Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. CordenPharma International API CDMO+CMC Service Platform Product Portfolio Table 60. CordenPharma International Recent Development Table 61. Boehringer Ingelheim BioXcellence Company Information Table 62. Boehringer Ingelheim BioXcellence Business Overview Table 63. Boehringer Ingelheim BioXcellence API CDMO+CMC Service Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Boehringer Ingelheim BioXcellence API CDMO+CMC Service Platform Product Portfolio Table 65. Boehringer Ingelheim BioXcellence Recent Development Table 66. Recipharm AB Company Information Table 67. Recipharm AB Business Overview Table 68. Recipharm AB API CDMO+CMC Service Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Recipharm AB API CDMO+CMC Service Platform Product Portfolio Table 70. Recipharm AB Recent Development Table 71. Changsha Jingyi Pharmaceutical Technology Co., Ltd. Company Information Table 72. Changsha Jingyi Pharmaceutical Technology Co., Ltd. Business Overview Table 73. Changsha Jingyi Pharmaceutical Technology Co., Ltd. API CDMO+CMC Service Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Changsha Jingyi Pharmaceutical Technology Co., Ltd. API CDMO+CMC Service Platform Product Portfolio Table 75. Changsha Jingyi Pharmaceutical Technology Co., Ltd. Recent Development Table 76. GlaxoSmithKline Company Information Table 77. GlaxoSmithKline Business Overview Table 78. GlaxoSmithKline API CDMO+CMC Service Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. GlaxoSmithKline API CDMO+CMC Service Platform Product Portfolio Table 80. GlaxoSmithKline Recent Development Table 81. Samsung BioLogics Company Information Table 82. Samsung BioLogics Business Overview Table 83. Samsung BioLogics API CDMO+CMC Service Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Samsung BioLogics API CDMO+CMC Service Platform Product Portfolio Table 85. Samsung BioLogics Recent Development Table 86. Emergent BioSolutions Company Information Table 87. Emergent BioSolutions Business Overview Table 88. Emergent BioSolutions API CDMO+CMC Service Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Emergent BioSolutions API CDMO+CMC Service Platform Product Portfolio Table 90. Emergent BioSolutions Recent Development Table 91. North America API CDMO+CMC Service Platform Revenue by Type (2021-2026) & (US$ Million) Table 92. North America API CDMO+CMC Service Platform Revenue by Type (2027-2032) & (US$ Million) Table 93. North America API CDMO+CMC Service Platform Revenue by Application (2021-2026) & (US$ Million) Table 94. North America API CDMO+CMC Service Platform Revenue by Application (2027-2032) & (US$ Million) Table 95. North America API CDMO+CMC Service Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. North America API CDMO+CMC Service Platform Revenue by Country (2021-2026) & (US$ Million) Table 97. North America API CDMO+CMC Service Platform Revenue by Country (US$ Million) & (2027-2032) Table 98. Europe API CDMO+CMC Service Platform Revenue by Type (2021-2026) & (US$ Million) Table 99. Europe API CDMO+CMC Service Platform Revenue by Type (2027-2032) & (US$ Million) Table 100. Europe API CDMO+CMC Service Platform Revenue by Application (2021-2026) & (US$ Million) Table 101. Europe API CDMO+CMC Service Platform Revenue by Application (2027-2032) & (US$ Million) Table 102. Europe API CDMO+CMC Service Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Europe API CDMO+CMC Service Platform Revenue by Country (2021-2026) & (US$ Million) Table 104. Europe API CDMO+CMC Service Platform Revenue by Country (US$ Million) & (2027-2032) Table 105. China API CDMO+CMC Service Platform Revenue by Type (2021-2026) & (US$ Million) Table 106. China API CDMO+CMC Service Platform Revenue by Type (2027-2032) & (US$ Million) Table 107. China API CDMO+CMC Service Platform Revenue by Application (2021-2026) & (US$ Million) Table 108. China API CDMO+CMC Service Platform Revenue by Application (2027-2032) & (US$ Million) Table 109. Asia API CDMO+CMC Service Platform Revenue by Type (2021-2026) & (US$ Million) Table 110. Asia API CDMO+CMC Service Platform Revenue by Type (2027-2032) & (US$ Million) Table 111. Asia API CDMO+CMC Service Platform Revenue by Application (2021-2026) & (US$ Million) Table 112. Asia API CDMO+CMC Service Platform Revenue by Application (2027-2032) & (US$ Million) Table 113. Asia API CDMO+CMC Service Platform Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Asia API CDMO+CMC Service Platform Revenue by Region (US$ Million) & (2021-2026) Table 115. Asia API CDMO+CMC Service Platform Revenue by Region (US$ Million) & (2027-2032) Table 116. SAMEA API CDMO+CMC Service Platform Revenue by Type (2021-2026) & (US$ Million) Table 117. SAMEA API CDMO+CMC Service Platform Revenue by Type (2027-2032) & (US$ Million) Table 118. SAMEA API CDMO+CMC Service Platform Revenue by Application (2021-2026) & (US$ Million) Table 119. SAMEA API CDMO+CMC Service Platform Revenue by Application (2027-2032) & (US$ Million) Table 120. SAMEA API CDMO+CMC Service Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. SAMEA API CDMO+CMC Service Platform Revenue by Country (2021-2026) & (US$ Million) Table 122. SAMEA API CDMO+CMC Service Platform Revenue by Country (US$ Million) & (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. API CDMO+CMC Service Platform Image Figure 2. Global API CDMO+CMC Service Platform Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global API CDMO+CMC Service Platform Market Size Share 2021 VS 2025 VS 2032 Figure 4. Comprehensive CDMO Platform Image Figure 5. Professional CDMO Platform Image Figure 6. International CDMO Platform Image Figure 7. Global API CDMO+CMC Service Platform Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global API CDMO+CMC Service Platform Market Size Share 2021 VS 2025 VS 2032 Figure 9. New Drug Development Image Figure 10. Clinical Stage Production Image Figure 11. Commercial Production Image Figure 12. Global API CDMO+CMC Service Platform Market Size (US$ Million) & (2021-2032) Figure 13. Global API CDMO+CMC Service Platform Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global API CDMO+CMC Service Platform Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global API CDMO+CMC Service Platform Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global API CDMO+CMC Service Platform Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global API CDMO+CMC Service Platform Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global API CDMO+CMC Service Platform Revenue Market Share by Type (2021-2032) Figure 20. Global API CDMO+CMC Service Platform Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global API CDMO+CMC Service Platform Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global API CDMO+CMC Service Platform Revenue Market Share by Application (2021-2032) Figure 23. North America API CDMO+CMC Service Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America API CDMO+CMC Service Platform Revenue Share by Type (2021-2032) Figure 25. North America API CDMO+CMC Service Platform Revenue Share by Application (2021-2032) Figure 26. North America API CDMO+CMC Service Platform Revenue Share by Country (2021-2032) Figure 27. United States API CDMO+CMC Service Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada API CDMO+CMC Service Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico API CDMO+CMC Service Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe API CDMO+CMC Service Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe API CDMO+CMC Service Platform Revenue Share by Type (2021-2032) Figure 32. Europe API CDMO+CMC Service Platform Revenue Share by Application (2021-2032) Figure 33. Europe API CDMO+CMC Service Platform Revenue Share by Country (2021-2032) Figure 34. Germany API CDMO+CMC Service Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France API CDMO+CMC Service Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. API CDMO+CMC Service Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy API CDMO+CMC Service Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain API CDMO+CMC Service Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia API CDMO+CMC Service Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands API CDMO+CMC Service Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries API CDMO+CMC Service Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China API CDMO+CMC Service Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China API CDMO+CMC Service Platform Revenue Share by Type (2021-2032) Figure 44. China API CDMO+CMC Service Platform Revenue Share by Application (2021-2032) Figure 45. Asia API CDMO+CMC Service Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia API CDMO+CMC Service Platform Revenue Share by Type (2021-2032) Figure 47. Asia API CDMO+CMC Service Platform Revenue Share by Application (2021-2032) Figure 48. Asia API CDMO+CMC Service Platform Revenue Share by Region (2021-2032) Figure 49. Japan API CDMO+CMC Service Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea API CDMO+CMC Service Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India API CDMO+CMC Service Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia API CDMO+CMC Service Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan API CDMO+CMC Service Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia API CDMO+CMC Service Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA API CDMO+CMC Service Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA API CDMO+CMC Service Platform Revenue Share by Type (2021-2032) Figure 57. SAMEA API CDMO+CMC Service Platform Revenue Share by Application (2021-2032) Figure 58. SAMEA API CDMO+CMC Service Platform Revenue Share by Country (2021-2032) Figure 59. Brazil API CDMO+CMC Service Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina API CDMO+CMC Service Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile API CDMO+CMC Service Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia API CDMO+CMC Service Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru API CDMO+CMC Service Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia API CDMO+CMC Service Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel API CDMO+CMC Service Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE API CDMO+CMC Service Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey API CDMO+CMC Service Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran API CDMO+CMC Service Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt API CDMO+CMC Service Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Comprehensive CDMO Platform
  • Professional CDMO Platform
  • International CDMO Platform
Applications
  • New Drug Development
  • Clinical Stage Production
  • Commercial Production
Companies covered
  • Lonza Group
  • Catalent, Inc.
  • Thermo Fisher Scientific
  • Pfizer CentreOne
  • CordenPharma International
  • Boehringer Ingelheim BioXcellence
  • Recipharm AB
  • Changsha Jingyi Pharmaceutical Technology Co., Ltd.
  • GlaxoSmithKline
  • Samsung BioLogics
  • Emergent BioSolutions

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 API CDMO+CMC Service Platform Market by Type
  3. 1.2.1 Global API CDMO+CMC Service Platform Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Comprehensive CDMO Platform
  5. 1.2.3 Professional CDMO Platform
  6. 1.2.4 International CDMO Platform
  7. 1.3 API CDMO+CMC Service Platform Market by Application
  8. 1.3.1 Global API CDMO+CMC Service Platform Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 New Drug Development
  10. 1.3.3 Clinical Stage Production
  11. 1.3.4 Commercial Production
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 API CDMO+CMC Service Platform Market Dynamics
  1. 2.1 API CDMO+CMC Service Platform Industry Trends
  2. 2.2 API CDMO+CMC Service Platform Industry Drivers
  3. 2.3 API CDMO+CMC Service Platform Industry Opportunities and Challenges
  4. 2.4 API CDMO+CMC Service Platform Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global API CDMO+CMC Service Platform Market Perspective (2021-2032)
  2. 3.2 Global API CDMO+CMC Service Platform Growth Trends by Region
  3. 3.2.1 Global API CDMO+CMC Service Platform Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global API CDMO+CMC Service Platform Market Size by Region (2021-2026)
  5. 3.2.3 Global API CDMO+CMC Service Platform Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global API CDMO+CMC Service Platform Revenue by Players
  2. 4.1.1 Global API CDMO+CMC Service Platform Revenue by Players (2021-2026)
  3. 4.1.2 Global API CDMO+CMC Service Platform Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global API CDMO+CMC Service Platform Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global API CDMO+CMC Service Platform Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global API CDMO+CMC Service Platform Key Players Headquarters & Area Served
  7. 4.4 Global API CDMO+CMC Service Platform Players, Product Type & Application
  8. 4.5 Global API CDMO+CMC Service Platform Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global API CDMO+CMC Service Platform Market CR5 and HHI
  11. 4.6.3 2025 API CDMO+CMC Service Platform Tier 1, Tier 2, and Tier 3
5 API CDMO+CMC Service Platform Market Size by Type
  1. 5.1 Global API CDMO+CMC Service Platform Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global API CDMO+CMC Service Platform Revenue by Type (2021-2032)
  3. 5.3 Global API CDMO+CMC Service Platform Revenue Market Share by Type (2021-2032)
6 API CDMO+CMC Service Platform Market Size by Application
  1. 6.1 Global API CDMO+CMC Service Platform Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global API CDMO+CMC Service Platform Revenue by Application (2021-2032)
  3. 6.3 Global API CDMO+CMC Service Platform Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Lonza Group
  2. 7.1.1 Lonza Group Company Information
  3. 7.1.2 Lonza Group Business Overview
  4. 7.1.3 Lonza Group API CDMO+CMC Service Platform Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Lonza Group API CDMO+CMC Service Platform Product Portfolio
  6. 7.1.5 Lonza Group Recent Developments
  7. 7.2 Catalent, Inc.
  8. 7.2.1 Catalent, Inc. Company Information
  9. 7.2.2 Catalent, Inc. Business Overview
  10. 7.2.3 Catalent, Inc. API CDMO+CMC Service Platform Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Catalent, Inc. API CDMO+CMC Service Platform Product Portfolio
  12. 7.2.5 Catalent, Inc. Recent Developments
  13. 7.3 Thermo Fisher Scientific
  14. 7.3.1 Thermo Fisher Scientific Company Information
  15. 7.3.2 Thermo Fisher Scientific Business Overview
  16. 7.3.3 Thermo Fisher Scientific API CDMO+CMC Service Platform Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Thermo Fisher Scientific API CDMO+CMC Service Platform Product Portfolio
  18. 7.3.5 Thermo Fisher Scientific Recent Developments
  19. 7.4 Pfizer CentreOne
  20. 7.4.1 Pfizer CentreOne Company Information
  21. 7.4.2 Pfizer CentreOne Business Overview
  22. 7.4.3 Pfizer CentreOne API CDMO+CMC Service Platform Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Pfizer CentreOne API CDMO+CMC Service Platform Product Portfolio
  24. 7.4.5 Pfizer CentreOne Recent Developments
  25. 7.5 CordenPharma International
  26. 7.5.1 CordenPharma International Company Information
  27. 7.5.2 CordenPharma International Business Overview
  28. 7.5.3 CordenPharma International API CDMO+CMC Service Platform Revenue and Gross Margin (2021-2026)
  29. 7.5.4 CordenPharma International API CDMO+CMC Service Platform Product Portfolio
  30. 7.5.5 CordenPharma International Recent Developments
  31. 7.6 Boehringer Ingelheim BioXcellence
  32. 7.6.1 Boehringer Ingelheim BioXcellence Company Information
  33. 7.6.2 Boehringer Ingelheim BioXcellence Business Overview
  34. 7.6.3 Boehringer Ingelheim BioXcellence API CDMO+CMC Service Platform Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Boehringer Ingelheim BioXcellence API CDMO+CMC Service Platform Product Portfolio
  36. 7.6.5 Boehringer Ingelheim BioXcellence Recent Developments
  37. 7.7 Recipharm AB
  38. 7.7.1 Recipharm AB Company Information
  39. 7.7.2 Recipharm AB Business Overview
  40. 7.7.3 Recipharm AB API CDMO+CMC Service Platform Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Recipharm AB API CDMO+CMC Service Platform Product Portfolio
  42. 7.7.5 Recipharm AB Recent Developments
  43. 7.8 Changsha Jingyi Pharmaceutical Technology Co., Ltd.
  44. 7.8.1 Changsha Jingyi Pharmaceutical Technology Co., Ltd. Company Information
  45. 7.8.2 Changsha Jingyi Pharmaceutical Technology Co., Ltd. Business Overview
  46. 7.8.3 Changsha Jingyi Pharmaceutical Technology Co., Ltd. API CDMO+CMC Service Platform Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Changsha Jingyi Pharmaceutical Technology Co., Ltd. API CDMO+CMC Service Platform Product Portfolio
  48. 7.8.5 Changsha Jingyi Pharmaceutical Technology Co., Ltd. Recent Developments
  49. 7.9 GlaxoSmithKline
  50. 7.9.1 GlaxoSmithKline Company Information
  51. 7.9.2 GlaxoSmithKline Business Overview
  52. 7.9.3 GlaxoSmithKline API CDMO+CMC Service Platform Revenue and Gross Margin (2021-2026)
  53. 7.9.4 GlaxoSmithKline API CDMO+CMC Service Platform Product Portfolio
  54. 7.9.5 GlaxoSmithKline Recent Developments
  55. 7.10 Samsung BioLogics
  56. 7.10.1 Samsung BioLogics Company Information
  57. 7.10.2 Samsung BioLogics Business Overview
  58. 7.10.3 Samsung BioLogics API CDMO+CMC Service Platform Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Samsung BioLogics API CDMO+CMC Service Platform Product Portfolio
  60. 7.10.5 Samsung BioLogics Recent Developments
  61. 7.11 Emergent BioSolutions
  62. 7.11.1 Emergent BioSolutions Company Information
  63. 7.11.2 Emergent BioSolutions Business Overview
  64. 7.11.3 Emergent BioSolutions API CDMO+CMC Service Platform Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Emergent BioSolutions API CDMO+CMC Service Platform Product Portfolio
  66. 7.11.5 Emergent BioSolutions Recent Developments
8 North America
  1. 8.1 North America API CDMO+CMC Service Platform Revenue (2021-2032)
  2. 8.2 North America API CDMO+CMC Service Platform Revenue by Type (2021-2032)
  3. 8.2.1 North America API CDMO+CMC Service Platform Revenue by Type (2021-2026)
  4. 8.2.2 North America API CDMO+CMC Service Platform Revenue by Type (2027-2032)
  5. 8.3 North America API CDMO+CMC Service Platform Revenue Share by Type (2021-2032)
  6. 8.4 North America API CDMO+CMC Service Platform Revenue by Application (2021-2032)
  7. 8.4.1 North America API CDMO+CMC Service Platform Revenue by Application (2021-2026)
  8. 8.4.2 North America API CDMO+CMC Service Platform Revenue by Application (2027-2032)
  9. 8.5 North America API CDMO+CMC Service Platform Revenue Share by Application (2021-2032)
  10. 8.6 North America API CDMO+CMC Service Platform Revenue by Country
  11. 8.6.1 North America API CDMO+CMC Service Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America API CDMO+CMC Service Platform Revenue by Country (2021-2026)
  13. 8.6.3 North America API CDMO+CMC Service Platform Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe API CDMO+CMC Service Platform Revenue (2021-2032)
  2. 9.2 Europe API CDMO+CMC Service Platform Revenue by Type (2021-2032)
  3. 9.2.1 Europe API CDMO+CMC Service Platform Revenue by Type (2021-2026)
  4. 9.2.2 Europe API CDMO+CMC Service Platform Revenue by Type (2027-2032)
  5. 9.3 Europe API CDMO+CMC Service Platform Revenue Share by Type (2021-2032)
  6. 9.4 Europe API CDMO+CMC Service Platform Revenue by Application (2021-2032)
  7. 9.4.1 Europe API CDMO+CMC Service Platform Revenue by Application (2021-2026)
  8. 9.4.2 Europe API CDMO+CMC Service Platform Revenue by Application (2027-2032)
  9. 9.5 Europe API CDMO+CMC Service Platform Revenue Share by Application (2021-2032)
  10. 9.6 Europe API CDMO+CMC Service Platform Revenue by Country
  11. 9.6.1 Europe API CDMO+CMC Service Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe API CDMO+CMC Service Platform Revenue by Country (2021-2026)
  13. 9.6.3 Europe API CDMO+CMC Service Platform Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China API CDMO+CMC Service Platform Revenue (2021-2032)
  2. 10.2 China API CDMO+CMC Service Platform Revenue by Type (2021-2032)
  3. 10.2.1 China API CDMO+CMC Service Platform Revenue by Type (2021-2026)
  4. 10.2.2 China API CDMO+CMC Service Platform Revenue by Type (2027-2032)
  5. 10.3 China API CDMO+CMC Service Platform Revenue Share by Type (2021-2032)
  6. 10.4 China API CDMO+CMC Service Platform Revenue by Application (2021-2032)
  7. 10.4.1 China API CDMO+CMC Service Platform Revenue by Application (2021-2026)
  8. 10.4.2 China API CDMO+CMC Service Platform Revenue by Application (2027-2032)
  9. 10.5 China API CDMO+CMC Service Platform Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia API CDMO+CMC Service Platform Revenue (2021-2032)
  2. 11.2 Asia API CDMO+CMC Service Platform Revenue by Type (2021-2032)
  3. 11.2.1 Asia API CDMO+CMC Service Platform Revenue by Type (2021-2026)
  4. 11.2.2 Asia API CDMO+CMC Service Platform Revenue by Type (2027-2032)
  5. 11.3 Asia API CDMO+CMC Service Platform Revenue Share by Type (2021-2032)
  6. 11.4 Asia API CDMO+CMC Service Platform Revenue by Application (2021-2032)
  7. 11.4.1 Asia API CDMO+CMC Service Platform Revenue by Application (2021-2026)
  8. 11.4.2 Asia API CDMO+CMC Service Platform Revenue by Application (2027-2032)
  9. 11.5 Asia API CDMO+CMC Service Platform Revenue Share by Application (2021-2032)
  10. 11.6 Asia API CDMO+CMC Service Platform Revenue by Country
  11. 11.6.1 Asia API CDMO+CMC Service Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia API CDMO+CMC Service Platform Revenue by Country (2021-2026)
  13. 11.6.3 Asia API CDMO+CMC Service Platform Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA API CDMO+CMC Service Platform Revenue (2021-2032)
  2. 12.2 SAMEA API CDMO+CMC Service Platform Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA API CDMO+CMC Service Platform Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA API CDMO+CMC Service Platform Revenue by Type (2027-2032)
  5. 12.3 SAMEA API CDMO+CMC Service Platform Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA API CDMO+CMC Service Platform Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA API CDMO+CMC Service Platform Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA API CDMO+CMC Service Platform Revenue by Application (2027-2032)
  9. 12.5 SAMEA API CDMO+CMC Service Platform Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA API CDMO+CMC Service Platform Revenue by Country
  11. 12.6.1 SAMEA API CDMO+CMC Service Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA API CDMO+CMC Service Platform Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA API CDMO+CMC Service Platform Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst